This table shows how much of what BC has ordered, both of vaccines which have been approved and those for which the orders are more ah theoretical.
| Manufacturer (type, effectiveness) | # People | # BC People | Status | Expected EUA* |
| Pfizer (mRNA, 95%) | 20M-38M | 2.5-4.75M | Approved | 2020-12-09 |
| Moderna (mRNA, 94.5%) | 22M | 2.75M | Approved | 2020-12-23 |
| AstraZeneca / Oxford (DNA, 62%) | 10M | 1.25M | Approved | 2021-02-26 |
| Serum Institute of India / COVISHIELD (AZ [1]) | 1M | .125M | Approved | 2021-02-26 |
| J&J/Janssen (DNA, 57-72%, one-shot) | 10M–38M | 1.25-4.75M | Approved | 2021-03-05 |
| COVAX, (Pfizer, AZ, J&J, Novavax, Sanofi) | 7.5Mish[2] | ~1.85M | Some approved | [2] |
| Novavax (protein, 96.4%/48.6% SA) | 26M–38M | 3.25M-4.75M | Approved | 2022-02-17 |
| Medicago (virus-like particle, 71%) | 10M–38M | 1.25-4.75M | Ph3 done Ph3 done 2021-12-07 | 2022-02-24 |
| Sanofi/GSK (mRNA, ?) | 26M–36M | 3.25M-4.5M | Ph3 done 2022-02-23 | 2022-Q2? |
| Providence Therapeutics (mRNA) | Started P1 trials 2021-01-26 | 2021-08-01? |
Note that I say “people”, not doses, to cope with the vaccines having different numbers of doses per person. Janssen uses one dose, while all the others are two doses per person.
* EUA = “Emergency Use Authorization”, a faster approval process than is normal for vaccines.
[1] Serum Institute of India manufactures the AstraZeneca under sublicense, under the name COVISHIELD, in association with Verity Pharmaceuticals Canada Inc.
[2] COVAX is a buyer’s coop, led by the World Health Organization, with a lot of different vaccines. Alas, I have not yet found an authoritative list of which vaccines it has. Canada has a contract to get 15M doses through COVAX, but it is not clear how much of which specific vaccines, which means I can’t say exactly how many people that will vaccinate.